Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
2.800
-0.100 (-3.45%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $28.72 million as of April 17, 2025. Its market cap has decreased by -62.16% in one year.
Market Cap
28.72M
Enterprise Value
-35.33M
1-Year Change
-62.16%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $28.72M, a decrease of -98.85%. That is a compound annual growth rate of -60.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 28.72M | -58.52% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |